As the GLP-1 Era Reshapes Weight Management, METAbiotics Launches with Science Designed to Support Long-Term Success
As the GLP-1 Era Reshapes Weight Management, METAbiotics Launches with Science Designed to Support Long-Term Success
WILMINGTON, Del., Aug. 3, 2026
New consumer health brand translates decades of original Akkermansia muciniphila research into evidence-based postbiotic supplements
WILMINGTON, Del., Aug. 3, 2026 /PRNewswire/ — Today, Danone subsidiary The Akkermansia Company announced the U.S. launch of METAbiotics, a science-backed postbiotic brand developed from decades of pioneering research into Akkermansia muciniphila and designed to support sustained weight management and metabolic health. The launch comes as long-term weight maintenance emerges as one of the defining challenges of the GLP-1 era
While millions of people are achieving significant weight loss through GLP-1 medications, maintaining that progress over time has become an increasingly important focus for consumers, healthcare professionals, and researchers alike
“Most supplement brands license an ingredient. We discovered one,” said Michael Oredsson, CEO of The Akkermansia Company. “Science isn’t simply a proof point for METAbiotics, it’s our foundation. Every product begins with original discovery and years of rigorous research, designed to help people support their health across every stage of life.”
The scientists behind METAbiotics discovered, named, and advanced the science of Akkermansia muciniphila, one of the most researched next-generation microbes in the world. That work led to pasteurized Akkermansia muciniphila MucT®, a proven postbiotic that underpins the METAbiotics line
“Your gut does far more than digest food,” said Professor Willem M. de Vos, who led the research team that first isolated and characterized Akkermansia muciniphilaand co-founded The Akkermansia Company. “AkkermansiaMucT® strengthens the gut barrier, which has a measurable, positive effect on metabolic health. The clinical evidence supporting our patented strain in weight loss maintenance is an exciting step forward.”
METAbiotics launches with two formulations designed to address distinct dimensions of metabolic wellness. The first, METAbiotics Weight Manager, is formulated to support healthy weight management and help maintain weight loss over time
In a randomized clinical study, participants taking Akkermansia muciniphila MucT® were 8 times more likely to maintain their weight loss during the maintenance phase than those on a placebo.*
The second formulation, METAbiotics Metabolic Strength, is designed to support the body’s natural metabolic adaptability, or its capacity to respond to everyday changes in diet, sleep, stress, aging, medications, and weight, while supporting healthy glucose metabolism, insulin function, gut barrier function, immune response, blood pressure, and overall metabolic health
METAbiotics is available now in the U.S. at shopmetabiotics.com and on Amazon
About METAbiotics The Akkermansia CompanyMETAbiotics is a consumer health brand from The Akkermansia Company, a Danone subsidiary dedicated to advancing the science of Akkermansia muciniphila. Built on decades of pioneering microbiome research, METAbiotics develops evidence-based postbiotic formulations that support metabolic adaptability, healthy weight management, and long-term metabolic health
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease
View original content to download multimedia:https://www.prnewswire.com/news-releases/as-the-glp-1-era-reshapes-weight-management-metabiotics-launches-with-science-designed-to-support-long-term-success-302841370.html
SOURCE METAbiotics The Akkermansia Company
The articles, information, and content displayed on this webpage may
include materials prepared and provided by third parties. Such
third-party content is offered for informational purposes only and
is not endorsed, reviewed, or verified by Morningstar
Morningstar makes no representations or warranties regarding the
accuracy, completeness, timeliness, or reliability of any third-party
content displayed on this site. The views and opinions expressed in
third-party content are those of the respective authors and do not
necessarily reflect the views of Morningstar, its affiliates, or employees
Morningstar is not responsible for any errors, omissions, or delays
in this content, nor for any actions taken in reliance thereon.
Users are advised to exercise their own judgment and seek independent
financial advice before making any decisions based on such content.
The third-party providers of this content are not affiliated with
Morningstar, and their inclusion on this site does not imply any
form of partnership, agency, or endorsement
Plus, updates on Microsoft, Meta, Amazon, and Apple.
Susan DziubinskiAug 3, 2026
These dividend stocks offer the best of all worlds: high yields, appreciation potential, and dividend stability.
Susan DziubinskiJul 29, 2026
The stocks of these high-quality companies look cheap today.
Tori BrovetAug 3, 2026
These undervalued stocks offer growth at a reasonable price.
Susan DziubinskiAug 4, 2026
When fund fundamentals and performance get ugly.
Vedran BeogradlijaJul 30, 2026
